ToxStrategies Welcomes Brent Finley, Ph.D., DABT
ToxStrategies is pleased to announce that nationally recognized toxicologist Dr. Brent Finley has joined our firm as an Executive Vice President. Dr. Finley… read more
Latest News
EpidStrategies Supports Neuralace Medical Submission for FDA Approval of Axon Therapy
Neuralace Medical recently received FDA clearance of Axon Therapy for diabetic patients suffering from chronic painful neuropathy. The EpidStrategies medical device trials team… read more
HEORStrategies’ Dr. Naomi Sacks is a Co-Author on a Study of Trends in Myasthenia Gravis Hospitalizations and Mortality
Dr. Naomi Sacks, HEORStrategies Vice President, is a co-author of a study on myasthenia gravis (MG) just published in the journal Neurology. MG… read more
ToxStrategies’ Scientists Publish Data Supporting Safety of Dietary Nitrate in Pigs
ToxStrategies’ scientists Amy Sheppard and Jennifer van de Ligt collaborated with a team of industry scientists from Cargill to evaluate the safety of… read more
ToxStrategies at IPPE 2024 – Atlanta, GA (Booth #A215)
ToxStrategies will be attending and exhibiting at the International Production & Processing Expo (IPPE) in Atlanta, GA from January 30 to February 1,… read more
EPA Begins TSCA Prioritization Process for Five Chemicals
The US Environmental Protection Agency (EPA) has announced that it is beginning the 12-month process to prioritize five additional chemicals for risk evaluation… read more
New Publication Assessing Risk from Perfluorocarboxylic Acids in Fluorinated HDPE Containers
ToxStrategies scientists LeeAnn Racz, Alison Gauthier, Jennifer Bare, Melissa Heintz, David Feifarek, Stephanie Kennedy, and Julie Panko assessed the risk of human and… read more
ToxStrategies’ Scientists Publish Cobalt Bioavailability Comparison Study
ToxStrategies’ scientist Jennifer van de Ligt collaborated with a team of industry scientists to compare tissue cobalt concentrations and growth performance of beef… read more